Morishita Jintan Co., Ltd. Stock

Equities

4524

JP3924400009

Food Processing

Market Closed - Japan Exchange 12:46:35 2024-05-21 am EDT 5-day change 1st Jan Change
2,196 JPY +0.09% Intraday chart for Morishita Jintan Co., Ltd. -0.86% +0.92%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 9.56B 61.23M Sales 2023 11.36B 72.73M Capitalization 8.16B 52.28M
Net income 2022 283M 1.81M Net income 2023 491M 3.14M EV / Sales 2022 0.66 x
Net cash position 2022 1.35B 8.66M Net cash position 2023 1.87B 11.99M EV / Sales 2023 0.55 x
P/E ratio 2022
27.2 x
P/E ratio 2023
16.6 x
Employees 328
Yield 2022
1.99%
Yield 2023
2%
Free-Float 53.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.09%
1 week-1.74%
Current month-7.89%
1 month-5.47%
3 months-12.51%
6 months+0.27%
Current year+0.92%
More quotes
1 week
2 175.00
Extreme 2175
2 229.00
1 month
2 175.00
Extreme 2175
2 520.00
Current year
2 175.00
Extreme 2175
2 644.00
1 year
1 960.00
Extreme 1960
2 644.00
3 years
1 860.00
Extreme 1860
2 644.00
5 years
1 664.00
Extreme 1664
2 644.00
10 years
1 664.00
Extreme 1664
4 150.00
More quotes
Managers TitleAgeSince
President 51 06-12-31
Chief Administrative Officer - -
Director/Board Member 69 12-06-30
Members of the board TitleAgeSince
Director/Board Member 65 20-06-26
Director/Board Member 61 13-05-31
President 51 06-12-31
More insiders
Date Price Change Volume
24-05-21 2,196 +0.09% 600
24-05-20 2,194 -0.23% 3,900
24-05-17 2,199 +0.50% 2,200
24-05-16 2,188 -1.04% 7,600
24-05-15 2,211 -1.07% 2,300

Delayed Quote Japan Exchange, May 21, 2024 at 12:46 am EDT

More quotes
MORISHITA JINTAN CO., LTD. is principally engaged in the manufacture and sale of health-related products. The Company operates in two segments. The Healthcare segment provides health-related products through Internet and major domestic companies. The Capsules segment is engaged in the contracting business of capsule bulks to food manufacturers and pharmaceutical manufacturers.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW